"#",Jurisdiction,Kind,Display Key,Lens ID,Publication Date,Publication Year,Application Number,Application Date,Priority Numbers,Earliest Priority Date,Title,Abstract,Applicants,Inventors,Owners,URL,Document Type,Has Full Text,Cites Patent Count,Cited by Patent Count,Simple Family Size,Extended Family Size,Sequence Count,CPC Classifications,IPCR Classifications,US Classifications,NPL Citation Count,NPL Resolved Citation Count,NPL Resolved Lens ID(s),NPL Resolved External ID(s),NPL Citations,Legal Status
1,WO,A1,WO 2022/040580 A1,196-104-294-931-77X,2022-02-24,2022,US 2021/0046984 W,2021-08-20,US 202063068904 P,2020-08-21,COMPOSITIONS AND METHODS FOR TARGETING TUMOR-ASSOCIATED MACROPHAGES,"The present invention relates to compounds that target monocytes, macrophages and other cells (such as dendritic cells) that express CD-206, particularly those cells at are assembled at a site of disease, using a target moiety coupled to a glucan backbone. The compounds disclosed here preferably comprise a glucan backbone, a targeting moiety, a targeting moiety linker, a payload and optionally a payload linker. The present invention also provides methods of making such compounds and compositions. The present invention also provides diagnostic methods and methods of treatment using compounds comprising a target moiety coupled to a glucan backbone.",RESOLUTE SCIENCE,BARNETT FAITH,,https://lens.org/196-104-294-931-77X,Patent Application,yes,4,0,9,9,0,G01N33/58;;G01N33/56972;;G01N2333/70596;;A61K47/61;;A61K47/549;;A61K49/0043;;A61K49/0054;;A61K49/0052;;A61K49/006;;A61K47/65;;A61K49/085;;A61K49/128;;A61K51/065;;G01N33/58;;G01N2333/70596;;G01N33/56972;;A61K49/0043;;A61K47/549;;A61K51/065;;A61K49/085;;A61K49/0054;;A61K49/006;;A61K47/61;;A61K49/0052;;A61K49/128;;A61K47/65;;A61K47/61;;A61K47/549;;A61K47/65;;A61K51/065;;A61K49/0054;;A61K49/0052;;A61K49/006;;A61K49/085;;A61K47/61;;A61K47/542;;A61K47/549;;A61K49/0054;;A61K51/06,A61K31/721;;A61K31/724;;A61K47/50;;A61K47/69;;G01N33/58;;G01N33/60,,2,2,097-359-350-195-662;;000-159-863-939-502,30691115;;10.3390/molecules24030439;;pmc6384580;;10.1134/s0026893317010137;;28251974;;10.7868/s002689841701013x,"SHIBAGUCHI KAI, TAMURA ATSUSHI, TERAUCHI MASAHIKO, MATSUMURA MITSUAKI, MIURA HIROYUKI, YUI NOBUHIKO: ""Mannosylated Polyrotaxanes for Increasing Cellular Uptake Efficiency in Macrophages through Receptor-Mediated Endocytosis"", MOLECULES, vol. 24, no. 3, 26 January 2019 (2019-01-26), XP055908341, DOI: 10.3390/molecules24030439;;MARKOV, OV ET AL.: ""Systemic Delivery of Complexes of Melanoma RNA with Mannosylated Liposomes Activates Highly Efficient Murine Melanoma-Specific Cytotoxic T Cells In Vivo"", MOLECULAR BIOLOGY, vol. 51, no. 1, 2017, pages 102 - 107, XP036164460, DOI: 10.1134/S0026893317010137",PENDING
2,IL,A,IL 300787 A,008-191-270-108-720,2023-04-01,2023,IL 30078723 A,2023-02-20,US 202063068904 P;;US 2021/0046984 W,2020-08-21,Compositions and methods for targeting tumor-associated macrophages,,RESOLUTE SCIENCE INC;;FAITH BARNETT,FAITH BARNETT,,https://lens.org/008-191-270-108-720,Patent Application,no,0,0,9,9,0,G01N33/58;;G01N33/56972;;G01N2333/70596;;A61K47/61;;A61K47/549;;A61K49/0043;;A61K49/0054;;A61K49/0052;;A61K49/006;;A61K47/65;;A61K49/085;;A61K49/128;;A61K51/065;;G01N33/58;;G01N2333/70596;;G01N33/56972;;A61K49/0043;;A61K47/549;;A61K51/065;;A61K49/085;;A61K49/0054;;A61K49/006;;A61K47/61;;A61K49/0052;;A61K49/128;;A61K47/65;;A61K47/61;;A61K47/549;;A61K47/65;;A61K51/065;;A61K49/0054;;A61K49/0052;;A61K49/006;;A61K49/085;;A61K47/61;;A61K47/542;;A61K47/549;;A61K49/0054;;A61K51/06,A61K47/54;;A61K47/61;;A61K47/65;;A61K49/00;;A61K49/08;;A61K49/12;;A61K51/06;;G01N33/569;;G01N33/58,,0,0,,,,PENDING
3,KR,A,KR 20230058086 A,171-133-502-572-798,2023-05-02,2023,KR 20237009697 A,2021-08-20,US 202063068904 P;;US 2021/0046984 W,2020-08-21,종양-관련 대식세포 표적화용 조성물 및 방법,"본 발명은 단핵구, 대식세포 및 CD-206을 발현하는 다른 세포(예컨대 수지상 세포), 특히 글루칸 백본에 커플링된 표적 모이어티를 사용한, 질환 부위에서 모이는 세포를 표적화하는 화합물에 관한 것이다. 본원에 개시된 화합물은 바람직하게는 글루칸 백본, 표적화 모이어티, 표적화 모이어티 링커, 페이로드 및 임의로 페이로드 링커를 포함한다. 본 발명은 또한 이러한 화합물 및 조성물을 제조하는 방법을 제공한다. 본 발명은 또한 글루칸 백본에 커플링된 표적 모이어티를 포함하는 화합물을 사용하는 진단 방법 및 치료 방법을 제공한다.",RESOLUTE SCIENCE INC,BARNETT FAITH,,https://lens.org/171-133-502-572-798,Patent Application,no,0,0,9,9,0,G01N33/58;;G01N33/56972;;G01N2333/70596;;A61K47/61;;A61K47/549;;A61K49/0043;;A61K49/0054;;A61K49/0052;;A61K49/006;;A61K47/65;;A61K49/085;;A61K49/128;;A61K51/065;;G01N33/58;;G01N2333/70596;;G01N33/56972;;A61K49/0043;;A61K47/549;;A61K51/065;;A61K49/085;;A61K49/0054;;A61K49/006;;A61K47/61;;A61K49/0052;;A61K49/128;;A61K47/65;;A61K47/61;;A61K47/549;;A61K47/65;;A61K51/065;;A61K49/0054;;A61K49/0052;;A61K49/006;;A61K49/085;;A61K47/61;;A61K47/542;;A61K47/549;;A61K49/0054;;A61K51/06,A61K47/61;;A61K47/54;;A61K47/65;;A61K49/00;;A61K49/08;;A61K51/06,,0,0,,,,PENDING
4,CA,A1,CA 3192041 A1,098-122-955-413-897,2022-02-24,2022,CA 3192041 A,2021-08-20,US 202063068904 P;;US 2021/0046984 W,2020-08-21,COMPOSITIONS AND METHODS FOR TARGETING TUMOR-ASSOCIATED MACROPHAGES,"The present invention relates to compounds that target monocytes, macrophages and other cells (such as dendritic cells) that express CD-206, particularly those cells at are assembled at a site of disease, using a target moiety coupled to a glucan backbone. The compounds disclosed here preferably comprise a glucan backbone, a targeting moiety, a targeting moiety linker, a payload and optionally a payload linker. The present invention also provides methods of making such compounds and compositions. The present invention also provides diagnostic methods and methods of treatment using compounds comprising a target moiety coupled to a glucan backbone.",RESOLUTE SCIENCE INC,BARNETT FAITH,,https://lens.org/098-122-955-413-897,Patent Application,no,0,0,9,9,0,G01N33/58;;G01N33/56972;;G01N2333/70596;;A61K47/61;;A61K47/549;;A61K49/0043;;A61K49/0054;;A61K49/0052;;A61K49/006;;A61K47/65;;A61K49/085;;A61K49/128;;A61K51/065;;G01N33/58;;G01N2333/70596;;G01N33/56972;;A61K49/0043;;A61K47/549;;A61K51/065;;A61K49/085;;A61K49/0054;;A61K49/006;;A61K47/61;;A61K49/0052;;A61K49/128;;A61K47/65;;A61K47/61;;A61K47/549;;A61K47/65;;A61K51/065;;A61K49/0054;;A61K49/0052;;A61K49/006;;A61K49/085;;A61K47/61;;A61K47/542;;A61K47/549;;A61K49/0054;;A61K51/06,A61K31/721;;A61K31/724;;A61K47/50;;A61K47/69;;G01N33/58;;G01N33/60,,0,0,,,,PENDING
5,EP,A1,EP 4199936 A1,160-036-223-921-605,2023-06-28,2023,EP 21859232 A,2021-08-20,US 202063068904 P;;US 2021/0046984 W,2020-08-21,COMPOSITIONS AND METHODS FOR TARGETING TUMOR-ASSOCIATED MACROPHAGES,,RESOLUTE SCIENCE INC,BARNETT FAITH,,https://lens.org/160-036-223-921-605,Patent Application,yes,0,0,9,9,0,G01N33/58;;G01N33/56972;;G01N2333/70596;;A61K47/61;;A61K47/549;;A61K49/0043;;A61K49/0054;;A61K49/0052;;A61K49/006;;A61K47/65;;A61K49/085;;A61K49/128;;A61K51/065;;G01N33/58;;G01N2333/70596;;G01N33/56972;;A61K49/0043;;A61K47/549;;A61K51/065;;A61K49/085;;A61K49/0054;;A61K49/006;;A61K47/61;;A61K49/0052;;A61K49/128;;A61K47/65;;A61K47/61;;A61K47/549;;A61K47/65;;A61K51/065;;A61K49/0054;;A61K49/0052;;A61K49/006;;A61K49/085;;A61K47/61;;A61K47/542;;A61K47/549;;A61K49/0054;;A61K51/06,A61K31/721;;A61K31/724;;A61K47/50;;A61K47/69;;G01N33/58;;G01N33/60,,0,0,,,,PENDING
6,AU,A1,AU 2021/327392 A1,087-088-394-819-858,2023-04-27,2023,AU 2021/327392 A,2021-08-20,US 202063068904 P;;US 2021/0046984 W,2020-08-21,COMPOSITIONS AND METHODS FOR TARGETING TUMOR-ASSOCIATED MACROPHAGES,"The present invention relates to compounds that target monocytes, macrophages and other cells (such as dendritic cells) that express CD-206, particularly those cells at are assembled at a site of disease, using a target moiety coupled to a glucan backbone. The compounds disclosed here preferably comprise a glucan backbone, a targeting moiety, a targeting moiety linker, a payload and optionally a payload linker. The present invention also provides methods of making such compounds and compositions. The present invention also provides diagnostic methods and methods of treatment using compounds comprising a target moiety coupled to a glucan backbone.",RESOLUTE SCIENCE INC,BARNETT FAITH,RESOLUTE SCIENCE INC (2023-04-27),https://lens.org/087-088-394-819-858,Patent Application,no,0,0,9,9,0,G01N33/58;;G01N33/56972;;G01N2333/70596;;A61K47/61;;A61K47/549;;A61K49/0043;;A61K49/0054;;A61K49/0052;;A61K49/006;;A61K47/65;;A61K49/085;;A61K49/128;;A61K51/065;;G01N33/58;;G01N2333/70596;;G01N33/56972;;A61K49/0043;;A61K47/549;;A61K51/065;;A61K49/085;;A61K49/0054;;A61K49/006;;A61K47/61;;A61K49/0052;;A61K49/128;;A61K47/65;;A61K47/61;;A61K47/549;;A61K47/65;;A61K51/065;;A61K49/0054;;A61K49/0052;;A61K49/006;;A61K49/085;;A61K47/61;;A61K47/542;;A61K47/549;;A61K49/0054;;A61K51/06,A61K31/721;;A61K31/724;;A61K47/50;;A61K47/69;;G01N33/58;;G01N33/60,,0,0,,,,PENDING
7,US,A1,US 2024/0009314 A1,062-729-042-001-18X,2024-01-11,2024,US 202118022095 A,2021-08-20,US 202118022095 A;;US 202063068904 P;;US 2021/0046984 W,2020-08-21,COMPOSITIONS AND METHODS FOR TARGETING TUMOR-ASSOCIATED MACROPHAGES,"The present invention relates to compounds that target monocytes, macrophages and other cells (such as dendritic cells) that express CD-206, particularly those cells at are assembled at a site of disease, using a target moiety coupled to a glucan backbone. The compounds disclosed here preferably comprise a glucan backbone, a targeting moiety, a targeting moiety linker, a payload and optionally a payload linker. The present invention also provides methods of making such compounds and compositions. The present invention also provides diagnostic methods and methods of treatment using compounds comprising a target moiety coupled to a glucan backbone.",RESOLUTE SCIENCE,BARNETT FAITH HEMENWAY,RESOLUTE SCIENCE INC (2023-09-08),https://lens.org/062-729-042-001-18X,Patent Application,yes,0,0,9,9,0,G01N33/58;;G01N33/56972;;G01N2333/70596;;A61K47/61;;A61K47/549;;A61K49/0043;;A61K49/0054;;A61K49/0052;;A61K49/006;;A61K47/65;;A61K49/085;;A61K49/128;;A61K51/065;;G01N33/58;;G01N2333/70596;;G01N33/56972;;A61K49/0043;;A61K47/549;;A61K51/065;;A61K49/085;;A61K49/0054;;A61K49/006;;A61K47/61;;A61K49/0052;;A61K49/128;;A61K47/65;;A61K47/61;;A61K47/549;;A61K47/65;;A61K51/065;;A61K49/0054;;A61K49/0052;;A61K49/006;;A61K49/085;;A61K47/61;;A61K47/542;;A61K47/549;;A61K49/0054;;A61K51/06,A61K47/61;;A61K47/54;;A61K49/00;;A61K51/06,,0,0,,,,PENDING
8,US,A1,US 2021/0187111 A1,084-949-541-187-903,2021-06-24,2021,US 202117150703 A,2021-01-15,US 202117150703 A;;US 2019/0041824 W;;US 201862699427 P,2018-07-17,COMPOSITIONS AND METHODS FOR DISRUPTING A MACROPHAGE NETWORK,"Described herein are methods and compositions for disrupting a macrophage network. Described herein are targeting agents capable of targeting one or more cells of a macrophage network. Methods for treating various diseases, such as cancer and granulomatous diseases are provided.",SCRIPPS HEALTH,BARNETT FAITH;;ROSENFELD MAURICIO,,https://lens.org/084-949-541-187-903,Patent Application,yes,0,0,2,2,0,G01N33/50;;G01N33/68;;A61K45/06;;A61P35/00;;G01N33/48;;A61K47/549;;A61K47/61;;G01N2800/24;;A61K39/46;;A61K47/61;;A61K47/549;;A61K47/6435;;A61P35/00;;A61K45/06,A61K47/54;;A61K45/06;;A61K47/61;;A61K47/64;;A61P35/00,,0,0,,,,DISCONTINUED
9,WO,A1,WO 2020/018434 A1,125-328-832-136-376,2020-01-23,2020,US 2019/0041824 W,2019-07-15,US 201862699427 P,2018-07-17,COMPOSITIONS AND METHODS FOR DISRUPTING A MACROPHAGE NETWORK,"Described herein are methods and compositions for disrupting a macrophage network. Described herein are targeting agents capable of targeting one or more cells of a macrophage network. Methods for treating various diseases, such as cancer and granulomatous diseases are provided.",SCRIPPS HEALTH,BARNETT FAITH;;ROSENFELD MAURICIO,,https://lens.org/125-328-832-136-376,Patent Application,yes,9,4,2,2,0,G01N33/50;;G01N33/68;;A61K45/06;;A61P35/00;;G01N33/48;;A61K47/549;;A61K47/61;;G01N2800/24;;A61K39/46;;A61K47/61;;A61K47/549;;A61K47/6435;;A61P35/00;;A61K45/06,A61K31/721;;A61K47/69;;C07K19/00;;G01N33/50;;G01N33/68,,8,8,032-699-461-427-932;;057-661-068-350-936;;055-186-890-443-309;;001-057-352-602-042;;052-422-712-552-601;;018-514-843-937-742;;049-293-871-793-166;;092-976-154-788-171,24046373;;pmc3791765;;10.1073/pnas.1312197110;;10.1038/srep36659;;27834402;;pmc5105153;;10.1021/acs.nanolett.7b02330;;10.1021/acs.nanolett.7b02330.s001;;28758755;;22586039;;10.4049/jimmunol.1103019;;pmc3370144;;pmc3963702;;10.13188/2325-4653.1000003;;24672807;;10.1182/blood-2008-07-167064;;18849484;;10.1021/acsnano.7b05465.s001;;10.1021/acsnano.7b05465;;28858473;;10.1158/1535-7163.mct-05-0313;;17121910,"CIESLEWICZ ET AL.: ""Targeted delivery of proapoptotic peptides to tumor-associated macrophages improves survival"", PROC NATL ACAD SCI USA, vol. 110, no. 40, 17 September 2013 (2013-09-17), pages 15919 - 15924, XP055377492, DOI: 10.1073/pnas.1312197110;;BARNETT ET AL.: ""Macrophages form functional vascular mimicry channels in vivo"", SCIENTIFIC REPORTS, vol. 6, no. 36659, 11 November 2016 (2016-11-11), pages 1 - 16, XP055676633, DOI: 10.1038/srep36659;;HE ET AL.: ""Inflammatory Monocytes Loading Protease-Sensitive Nanoparticles Enable Lung Metastasis Targeting and Intelligent Drug Release for Anti-Metastasis Therapy"", NANO LETT, vol. 17, no. 9, 2 August 2017 (2017-08-02), pages 5546 - 5554;;SPEAR ET AL.: ""Chimeric antigen receptor T cells shape myeloid cell function within the tumor microenvironment through IFN-y and GM-CSF"", J IMMUNOL, vol. 188, no. 12, 14 May 2012 (2012-05-14), pages 6389 - 6398, XP055676635;;AZAD ET AL.: ""Exploitation of the Macrophage Mannose Receptor ( CD 206) in Infectious Disease Diagnostics and Therapeutics"", J CYTOL MOL BIOL, vol. 1, no. 1, 10 January 2014 (2014-01-10), pages 1 - 5, XP055676636;;FABRIEK ET AL.: ""The macrophage scavenger receptor CD 163 functions as an innate immune sensor for bacteria"", BLOOD, vol. 113, no. 4, 10 October 2008 (2008-10-10), pages 887 - 892, XP055676638;;QIAN ET AL.: ""Molecular-Targeted Immunotherapeutic Strategy for Melanoma via Dual-Targeting Nanoparticles Delivering Small Interfering RNA to Tumor-Associated Macrophages"", ACS NANO, vol. 11, no. 9, 6 September 2017 (2017-09-06), pages 9536 - 9549, XP055676639;;OHNO ET AL.: ""A c-fms tyrosine kinase inhibitor, Ki20227, suppresses osteoclast differentiation and osteolytic bone destruction in a bone metastasis model"", MOL CANCER THER, vol. 5, no. 11, 1 November 2006 (2006-11-01), pages 2634 - 2643, XP055285967, DOI: 10.1158/1535-7163.MCT-05-0313",PENDING
10,WO,A1,WO 2012/005763 A1,065-587-357-484-022,2012-01-12,2012,US 2011/0001183 W,2011-07-06,US 39908510 P,2010-07-06,USE OF MYELOID-LIKE PROGENITOR CELL POPULATIONS TO TREAT TUMORS,"This invention provides methods for treating tumors. The methods involve injecting or implanting a population of myeloid-like progenitor cells (e.g., human CD14 + cells or CD33 HI monocytes) to a subject afflicted with a tumor. The isolated cells can be further engineered to express an anti-tumor agent, e.g., an anti-angiogenic agent or a cytotoxic agent.",SCRIPPS RESEARCH INST;;BARNETT FAITH;;FRIEDLANDER MARTIN;;MARCHETTI VALENTINA;;SCHEPPKE LEA,BARNETT FAITH;;FRIEDLANDER MARTIN;;MARCHETTI VALENTINA;;SCHEPPKE LEA,,https://lens.org/065-587-357-484-022,Patent Application,yes,6,8,1,1,0,A61K2035/124;;C12N5/0647;;C12N5/0645,C12N5/0789,,60,36,013-169-501-613-872;;088-102-712-010-523;;018-695-540-109-443;;029-439-099-355-008;;056-414-213-625-349;;057-472-181-666-171;;072-468-307-701-916;;132-216-675-405-508;;031-039-129-088-844;;020-178-335-962-88X;;014-074-797-627-660;;139-248-761-009-887;;014-222-571-326-744;;046-902-288-989-622;;001-324-677-468-148;;014-407-226-525-663;;021-830-969-285-535;;050-909-285-174-264;;032-975-719-283-904;;112-618-647-147-827;;000-662-341-536-675;;028-259-843-326-244;;087-028-066-754-798;;035-733-228-739-37X;;026-560-726-172-848;;113-853-885-867-236;;040-606-336-311-134;;002-460-381-540-764;;013-647-067-058-91X;;015-365-000-273-014;;031-380-014-290-902;;015-207-630-988-619;;107-193-420-961-208;;085-590-107-907-371;;089-822-826-436-33X;;101-092-006-505-986,10.1038/nm871;;12740570;;10.1016/j.exphem.2004.05.027;;15308326;;10.1172/jci29683;;pmc1636693;;17111048;;3410055;;10.1016/0014-5793(88)80077-2;;8045297;;10.1016/0014-5793(94)00621-0;;pmc45163;;7972006;;10.1073/pnas.91.23.11045;;10.1128/jvi.66.5.2731-2739.1992;;1560523;;pmc241028;;1531369;;pmc240899;;10.1128/jvi.66.3.1635-1640.1992;;10.1128/jvi.63.5.2374-2378.1989;;2784836;;pmc250661;;pmc240569;;10.1128/jvi.65.5.2220-2224.1991;;1850008;;7538814;;10.1182/blood.v85.11.3048.bloodjournal85113048;;pmc23727;;9342375;;10.1073/pnas.94.22.12133;;7570001;;10.1126/science.270.5235.475;;10.1007/s002620050349;;9111579;;10.1016/0042-6822(88)90101-8;;10.1016/s0042-6822(88)90101-8;;2462307;;10.1007/bf01310674;;1652237;;9287146;;10.1089/hum.1997.8.12-1459;;10.1182/blood.v92.11.4080;;9834213;;9923409;;10.1016/s1083-8791(98)50000-6;;10.1053/bbmt.1998.v4.pm9923409;;10466630;;10.1089/10430349950017329;;10.1038/sj.gt.3300932;;10455411;;10514266;;10.1021/bp990085b;;10.1021/bp000078j;;11027182;;10.1089/104303400750001408;;11044911;;11406764;;10.1038/sj.gt.3301456;;11545619;;10.1006/mthe.2001.0445;;10.1053/ejso.2002.1386;;12711288;;15079812;;10.1002/jgm.538;;10.1189/jlb.1003501;;14742640;;pmc1764452;;16246929;;10.1177/154405910508401105;;18234850;;10.1152/ajpcell.00437.2007;;pmc5921518;;10.1111/j.1349-7006.1997.tb00462.x;;9369934;;10.1093/oxfordjournals.eurheartj.a059693;;2156705;;8029539;;10.1016/0300-9572(94)90011-6;;15164099;;10.1038/sj.gt.3302287;;9924027;;10.1126/science.283.5402.682,"DE PALMA MICHELE ET AL: ""Targeting exogenous genes to tumor angiogenesis by transplantation of genetically modified hematopoietic stem cells"", NATURE MEDICINE, NATURE PUBLISHING GROUP, NEW YORK, NY, US, vol. 9, no. 6, 1 June 2003 (2003-06-01), pages 789 - 795, XP002527465, ISSN: 1078-8956, DOI: 10.1038/NM871;;ANNA SZAFLARSKA ET AL: ""Antitumor response of CD14+/CD16+ monocyte subpopulation"", EXPERIMENTAL HEMATOLOGY, vol. 32, no. 8, 1 August 2004 (2004-08-01), pages 748 - 755, XP055010354, ISSN: 0301-472X, DOI: 10.1016/j.exphem.2004.05.027;;""Academic Press Dictionary of Science and Technology"", 1992, ACADEMIC PRESS;;""Illustrated Dictionary of Immunology"", 2002, CRC PR I LLC;;""Oxford Dictionary of Biochemistry and Molecular Biology"", 2000, OXFORD UNIVERSITY PRESS;;""Encyclopaedic Dictionary of Chemistry"", 2002, ANMOL PUBLICATIONS PVT. LTD.;;""Dictionary ofmicrobiology and Molecular Biology"", 2002, JOHN WILEY & SONS;;""Dictionary of Chemistry"", 1999;;""Dictionary ofPharmaceutical Medicine"", 1994, SPRINGER-VERLAG TELOS;;""Dictionary of Organic Chemistry"", 2002, ANMOL PUBLICATIONS PVT. LTD.;;""A Dictionary ofBiology (Oxford Paperback Reference"", 2000, OXFORD UNIVERSITY PRESS;;RITTER ET AL., J. CLIN. INVEST., vol. 116, 2006, pages 3266 - 76;;""Flow cytometry - A practical approach"", 2000, OXFORD UNIVERSITY PRESS;;""Handbook of Flow Cytometry Methods"", 1993, WILEY-LISS;;CHEN ET AL., FEBS LETT, vol. 236, 1988, pages 462 - 466;;CORNUT ET AL., FEBS LETT, vol. 349, 1994, pages 29 - 33;;CASEY ET AL., ONCOGENE, vol. 6, 1991, pages 1791 - 7;;OKAMOTO, PROC. NATL. ACAD. SCI. U.S.A., vol. 91, 1994, pages 11045 - 9;;BUCHSCHER ET AL., J. VIROL., vol. 66, 1992, pages 2731 - 2739;;JOHANN ET AL., J. VIROL., vol. 66, 1992, pages 1635 - 1640;;SOMMERFELT ET AL., VIROL., vol. 176, 1990, pages 58 - 59;;WILSON ET AL., J. VIROL., vol. 63, 1989, pages 2374 - 2378;;MILLER ET AL., J VIROL., vol. 65, 1991, pages 2220 - 2224;;DUNBAR ET AL., BLOOD, vol. 85, 1995, pages 3048 - 305;;KOHN ET AL., NAT. MED., vol. 1, 1995, pages 1017 - 102;;MALECH ET AL., PROC. NATL. ACAD. SCI. US.A., vol. 94, no. 22, 1997, pages 12133 - 12138;;BLAESE ET AL., SCIENCE, vol. 270, 1995, pages 475 - 480;;ELLEM ET AL., IMMUNOL IMMUNOTHER, vol. 44, 1997, pages 10 - 20;;DRANOFF ET AL., HUM. GENE 7HER., vol. 1, 1997, pages 111 - 2;;SAMBROOK ET AL.: ""Molecular Cloning: A Laboratory Manual"", 1989, COLD SPRING HARBOR LABORATORY PRESS;;""Gene Expression Technology, Methods in Enzymology"", vol. 185, 1991, ACADEMIC PRESS;;INNIS ET AL.: ""PCR Protocols: A Guide to Methods and Applications"", 1990, ACADEMIC PRESS;;MARKOWITZ ET AL., VIROL., vol. 167, 1988, pages 400 - 6;;MEYERS ET AL., ARCH. VIROL., vol. 119, 1991, pages 257 - 64;;DAVIS ET AL., HUM. GENE. THER., vol. 8, 1997, pages 1459 - 67;;POVEY ET AL., BLOOD, vol. 92, 1998, pages 4080 - 9;;BAUER ET AL., BIOL. BLOOD MARROW TRANSPLANT, vol. 4, 1998, pages 119 - 27;;GERIN ET AL., HUM. GENE THER., vol. 10, 1999, pages 1965 - 74;;SEHGAL ET AL., GENE THER., vol. 6, 1999, pages 1084 - 91;;GERIN ET AL., BIOTECHNOL. PROG., vol. 15, 1999, pages 941 - 8;;MCTAGGART ET AL., BIOTECHNOL. PROG., vol. 16, 2000, pages 859 - 65;;REEVES ET AL., HUM. GENE. THER., vol. 11, 2000, pages 2093 - 103;;CHAN ET AL., GENE THER., vol. 8, 2001, pages 697 - 703;;THALER ET AL., MOL. THER., vol. 4, 2001, pages 273 - 9;;MARTINET ET AL., EUR. J. SURG. ONCOL., vol. 29, 2003, pages 351 - 7;;LEMOINE ET AL., I .GENE MED., vol. 6, 2004, pages 374 - 86;;MULLIGAN ET AL., HUM. GENE THER., vol. 5, 1993, pages 543 - 563;;UMLAND ET AL., J. LEU. BIOL., vol. 75, 2004, pages 671 - 679;;CHANG ET AL., J. DENT. RES., vol. 84, 2005, pages 994;;CRISOSTOMO ET AL., AM. J. PHYSIOL. CELL. PHYSIOL., vol. 294, 2008, pages C675 - C682;;""Remington: The Science and Practice ofPharmacy"", 2000, MACK PUBLISHING CO.;;IWASAKI ET AL., JPN. J. CANCER RES., vol. 88, 1997, pages 861 - 6;;JESPERSEN ET AL., EUR. HEART J., vol. 11, 1990, pages 269 - 74;;MARTENS, RESUSCITATION, vol. 27, 1994, pages 177;;""Goodman & Gilman's The Pharmacological Bases of Therapeutics"", 2001, MCGRAW-HILL;;""Remington: The Science and Practice ofPharmacy"", 2003, LIPPINCOTT WILLIAMS & WILKINS;;""Pharmaceutical Dosage Forms and Drug Delivery Systems"", 1999, LIPPINCOTT WILLIAMS & WILKINS;;BARNETT ET AL., GENE THERAPY, vol. 11, 2004, pages 1283 - 9;;RITTER ET AL., J. CLIN..INVEST., vol. 116, 2006, pages 3266 - 76;;MIYOSHI ET AL., SCIENCE, vol. 283, 1999, pages 682 - 686",PENDING
11,WO,A1,WO 2018/191248 A1,107-046-293-308-264,2018-10-18,2018,US 2018/0026860 W,2018-04-10,US 201762483932 P;;US 201762595579 P;;US 201862639492 P,2017-04-10,INTERCONNECT SYSTEM HAVING RETENTION FEATURES,Interconnect systems having anti-backout latches and securement members are disclosed.,SAMTEC INC,BETTMAN R;;PARKES LIAM;;ZBINDEN ERIC;;GUETIG KEITH;;SHAH JIGNESH;;WILLIAMS BARNETT JEAN;;FAITH CHADRICK,,https://lens.org/107-046-293-308-264,Patent Application,yes,7,0,9,23,0,G02B6/4284;;H01R12/7052;;H01R12/7058;;H01R12/721;;H01R12/73;;H01R13/502;;H01R13/639;;G02B6/4269;;G02B6/4284;;H01R12/7058;;H01R12/73,G02B6/42;;G02B6/36,,1,0,,,See also references of EP 3610311A4,PENDING
12,TW,S,TW D228623 S,196-436-015-288-058,2023-11-21,2023,TW 111304650 F,2022-09-16,US 202229831924 F,2022-03-23,ELECTRICAL CONNECTOR,﻿【物品用途】;本設計有關電連接器，其被配置為與另一個電連接器配合。每個電連接器可以具有相應的連接器外殼和由連接器外殼支撐的多個電接頭的形式。在一設計中，電連接器可以採用電纜連接器的形式，其具有由連接器外殼支撐並安裝到電接頭的電纜。;【設計說明】;(省略之),美商山姆科技公司 美國;;SAMTEC INC,GUETIG KEITH;;SCHMELZ DALE;;FAITH CHADRICK PAUL;;SHAH JIGNESH H;;WILLIAMS BARNETT JEAN KARLO;;BLANDO GUSTAVO,,https://lens.org/196-436-015-288-058,Design Right,no,0,0,1,1,0,,,13-03,0,0,,,,ACTIVE
13,CN,U,CN 207765710 U,038-780-522-287-088,2018-08-24,2018,CN 201721022289 U,2017-08-15,US 201662375050 P;;US 201762451566 P;;US 201762483932 P,2016-08-15,A prevent withdrawing from door bolt and detain for interconnection system,"A prevent withdrawing from door bolt and detain for interconnection system. A variously prevent withdrawing from the door bolt and detain that interconnection system removes between the position including can and breaking away from at the bonding station. In the time of in being in the bonding station, prevent withdrawing from the door bolt detain can by the structure for the module that preventsto interconnect, relieve from the primary module such as the light transceiver and pair. When be in break away from the position in the time, prevent withdrawing from the door bolt and detain and allow the interconnection module to relieve from the primary module to pair. Still disclose the module dustcoat fixed fixed part of radiator with the interconnection module.",SAMTEC INC,R BRAD BETTMAN;;LIAM PARKES;;KEITH GUETIG;;JIGNESH H SHAH;;ERIC ZBINDEN;;JEAN KARLO WILLIAMS BARNETT;;CHADRICK PAUL FAITH,,https://lens.org/038-780-522-287-088,Limited Patent,no,0,6,14,23,0,H01R12/7005;;H01R13/629;;H01R13/639;;H01R24/20;;H01R13/639;;G02B6/428;;G02B6/4214;;G02B6/4284;;H01R12/774;;H01R12/83;;H01R12/7058;;H01R12/7029;;G02B6/4246;;G02B6/4269;;G02B6/4277;;H01R12/7029;;H01R12/7058;;H01R12/774;;H01R12/83;;H01R13/639;;H01R13/629,H01R13/639;;H01R12/70;;H01R13/629;;H01R24/20,,0,0,,,,INACTIVE
14,TW,B,TW I735634 B,034-342-975-250-610,2021-08-11,2021,TW 106127615 A,2017-08-15,US 201662375050 P;;US 201762451566 P;;US 201762483932 P,2016-08-15,Anti-backout latch for interconnect system,,SAMTEC INC,BETTMAN R BRAD;;PARKES LIAM;;ZBINDEN ERIC;;GUETIG KEITH;;SHAH JIGNESH H;;WILLIAMS BARNETT JEAN KARLO;;FAITH CHADRICK PAUL,,https://lens.org/034-342-975-250-610,Granted Patent,no,5,0,14,23,0,H01R12/7005;;H01R13/629;;H01R13/639;;H01R24/20;;H01R13/639;;G02B6/428;;G02B6/4214;;G02B6/4284;;H01R12/774;;H01R12/83;;H01R12/7058;;H01R12/7029;;G02B6/4246;;G02B6/4269;;G02B6/4277;;H01R12/7029;;H01R12/7058;;H01R12/774;;H01R12/83;;H01R13/639;;H01R13/629,,,0,0,,,,ACTIVE
15,US,B2,US 11735844 B2,078-710-927-353-482,2023-08-22,2023,US 202117496558 A,2021-10-07,US 202117496558 A;;US 201916325456 A;;US 2017/0046918 W;;US 201662375050 P;;US 201762451566 P;;US 201762483932 P,2016-08-15,Anti-backout latch for interconnect system,"An interconnect system includes various anti-backout latches that are movable between an engaged position and a disengaged position. When in the engaged position, the anti-backout latches can be configured to prevent an interconnect module, such as an optical transceiver, from becoming unmated from a host module. When in the disengaged position, the anti-backout latches permit the interconnect module to become unmated from a host module. Securement members are also disclosed that secure a heat sink to a module housing of the interconnect module.",SAMTEC INC,PARKES LIAM;;ZBINDEN ERIC;;GUETIG KEITH;;SHAH JIGNESH H;;WILLIAMS BARNETT JEAN KARLO;;FAITH CHADRICK PAUL;;BETTMAN R BRAD,,https://lens.org/078-710-927-353-482,Granted Patent,yes,103,0,14,23,0,H01R12/7005;;H01R13/629;;H01R13/639;;H01R24/20;;H01R13/639;;G02B6/428;;G02B6/4214;;G02B6/4284;;H01R12/774;;H01R12/83;;H01R12/7058;;H01R12/7029;;G02B6/4246;;G02B6/4269;;G02B6/4277;;H01R12/7029;;H01R12/7058;;H01R12/774;;H01R12/83;;H01R13/639;;H01R13/629,H01R12/70;;G02B6/42;;H01R12/77;;H01R12/83;;H01R13/629;;H01R13/639,,1,0,,,"Samtec, 0.8MM Q-Rate Terminal Assembly by Clay W, Dwg. No. QRM8-XXX-XX.X-X-D-XX-A-XX, Aug. 27, 2008, 4 sheets.",ACTIVE
16,US,A1,US 2022/0029323 A1,090-922-077-259-64X,2022-01-27,2022,US 202117496558 A,2021-10-07,US 202117496558 A;;US 201916325456 A;;US 2017/0046918 W;;US 201662375050 P;;US 201762451566 P;;US 201762483932 P,2016-08-15,ANTI-BACKOUT LATCH FOR INTERCONNECT SYSTEM,"An interconnect system includes various anti-backout latches that are movable between an engaged position and a disengaged position. When in the engaged position, the anti-backout latches can be configured to prevent an interconnect module, such as an optical transceiver, from becoming unmated from a host module. When in the disengaged position, the anti-backout latches permit the interconnect module to become unmated from a host module. Securement members are also disclosed that secure a heat sink to a module housing of the interconnect module.",SAMTEC INC,PARKES LIAM;;ZBINDEN ERIC;;GUETIG KEITH;;SHAH JIGNESH H;;WILLIAMS BARNETT JEAN KARLO;;FAITH CHADRICK PAUL;;BETTMAN R BRAD,,https://lens.org/090-922-077-259-64X,Patent Application,yes,0,0,14,23,0,H01R12/7005;;H01R13/629;;H01R13/639;;H01R24/20;;H01R13/639;;G02B6/428;;G02B6/4214;;G02B6/4284;;H01R12/774;;H01R12/83;;H01R12/7058;;H01R12/7029;;G02B6/4246;;G02B6/4269;;G02B6/4277;;H01R12/7029;;H01R12/7058;;H01R12/774;;H01R12/83;;H01R13/639;;H01R13/629,H01R12/70;;G02B6/42;;H01R12/77;;H01R12/83;;H01R13/639,,0,0,,,,ACTIVE
17,TW,A,TW 201809772 A,061-958-661-125-862,2018-03-16,2018,TW 106127615 A,2017-08-15,US 201662375050 P;;US 201762451566 P;;US 201762483932 P,2016-08-15,Anti-backout latch for interconnect system,"An interconnect system includes various anti- -backout latches that are movable between an engaged position and a disengaged position. When in the engaged position, the anti-backout latches can be configured to prevent an interconnect module, such as an optical transceiver, from becoming unmated from a host module. When in the disengaged position, the anti-backout latches permit the interconnect module to become unmated from a host module. Securement members are also disclosed that secure a heat sink to a module housing of the interconnect module.",SAMTEC INC,BETTMAN R BRAD;;PARKES LIAM;;ZBINDEN ERIC;;GUETIG KEITH;;SHAH JIGNESH H;;WILLIAMS BARNETT JEAN KARLO;;FAITH CHADRICK PAUL,,https://lens.org/061-958-661-125-862,Patent of Addition,no,0,0,14,23,0,H01R12/7005;;H01R13/629;;H01R13/639;;H01R24/20;;H01R13/639;;G02B6/428;;G02B6/4214;;G02B6/4284;;H01R12/774;;H01R12/83;;H01R12/7058;;H01R12/7029;;G02B6/4246;;G02B6/4269;;G02B6/4277;;H01R12/7029;;H01R12/7058;;H01R12/774;;H01R12/83;;H01R13/639;;H01R13/629,G02B6/42,,0,0,,,,ACTIVE
18,US,B2,US 11171432 B2,036-960-875-233-363,2021-11-09,2021,US 201716325456 A,2017-08-15,US 201716325456 A;;US 201662375050 P;;US 201762451566 P;;US 201762483932 P;;US 2017/0046918 W,2016-08-15,Anti-backout latch for interconnect system,"An interconnect system includes various anti-backout latches that are movable between an engaged position and a disengaged position. When in the engaged position, the anti-backout latches can be configured to prevent an interconnect module, such as an optical transceiver, from becoming unmated from a host module. When in the disengaged position, the anti-backout latches permit the interconnect module to become unmated from a host module. Securement members are also disclosed that secure a heat sink to a module housing of the interconnect module.",SAMTEC INC,PARKES LIAM;;ZBINDEN ERIC;;GUETIG KEITH;;SHAH JIGNESH H;;WILLIAMS BARNETT JEAN KARLO;;FAITH CHADRICK PAUL;;BETTMAN R BRAD,SAMTEC INC (2016-08-24),https://lens.org/036-960-875-233-363,Granted Patent,yes,88,4,14,23,0,H01R12/7005;;H01R13/629;;H01R13/639;;H01R24/20;;H01R13/639;;G02B6/428;;G02B6/4214;;G02B6/4284;;H01R12/774;;H01R12/83;;H01R12/7058;;H01R12/7029;;G02B6/4246;;G02B6/4269;;G02B6/4277;;H01R12/7029;;H01R12/7058;;H01R12/774;;H01R12/83;;H01R13/639;;H01R13/629,H01R12/70;;G02B6/42;;H01R12/77;;H01R12/83;;H01R13/639,,1,0,,,"Samtec, .8MM Q-Rate Terminal Assembly by Clay W, Dwg. No. QRM8-XXX-XX.X-X-D-XX-A-XX, Aug. 27, 2008, 4 sheets.",ACTIVE
19,WO,A1,WO 2018/035108 A1,117-807-088-432-692,2018-02-22,2018,US 2017/0046918 W,2017-08-15,US 201662375050 P;;US 201762451566 P;;US 201762483932 P,2016-08-15,ANTI-BACKOUT LATCH FOR INTERCONNECT SYSTEM,"An interconnect system includes various anti-backout latches that are movable between an engaged position and a disengaged position. When in the engaged position, the anti-backout latches can be configured to prevent an interconnect module, such as an optical transceiver, from becoming unmated from a host module. When in the disengaged position, the anti-backout latches permit the interconnect module to become unmated from a host module. Securement members are also disclosed that secure a heat sink to a module housing of the interconnect module.",SAMTEC INC,PARKES LIAM;;ZBINDEN ERIC;;GUETIG KEITH;;SHAH JIGNESH H;;BARNETT JEAN KARLO WILIAMS;;FAITH CHADRICK PAUL;;BETTMAN R BRAD,,https://lens.org/117-807-088-432-692,Patent Application,yes,8,6,14,23,0,H01R12/7005;;H01R13/629;;H01R13/639;;H01R24/20;;H01R13/639;;G02B6/428;;G02B6/4214;;G02B6/4284;;H01R12/774;;H01R12/83;;H01R12/7058;;H01R12/7029;;G02B6/4246;;G02B6/4269;;G02B6/4277;;H01R12/7029;;H01R12/7058;;H01R12/774;;H01R12/83;;H01R13/639;;H01R13/629,H01R13/639;;G02B6/42;;H01R13/629,,0,0,,,,PENDING
20,EP,A4,EP 3497755 A4,129-571-771-521-718,2020-03-25,2020,EP 17841983 A,2017-08-15,US 201662375050 P;;US 201762451566 P;;US 201762483932 P;;US 2017/0046918 W,2016-08-15,ANTI-BACKOUT LATCH FOR INTERCONNECT SYSTEM,,SAMTEC INC,PARKES LIAM;;ZBINDEN ERIC;;GUETIG KEITH;;SHAH JIGNESH H;;BARNETT JEAN KARLO WILIAMS;;FAITH CHADRICK PAUL;;BETTMAN R BRAD,,https://lens.org/129-571-771-521-718,Search Report,no,2,0,14,23,0,H01R12/7005;;H01R13/629;;H01R13/639;;H01R24/20;;H01R13/639;;G02B6/428;;G02B6/4214;;G02B6/4284;;H01R12/774;;H01R12/83;;H01R12/7058;;H01R12/7029;;G02B6/4246;;G02B6/4269;;G02B6/4277;;H01R12/7029;;H01R12/7058;;H01R12/774;;H01R12/83;;H01R13/639;;H01R13/629,H01R13/639;;G02B6/42;;H01R12/70;;H01R12/77;;H01R12/83;;H01R13/629,,0,0,,,,PENDING
21,US,A1,US 2020/0403334 A1,190-214-339-285-88X,2020-12-24,2020,US 201716325456 A,2017-08-15,US 201716325456 A;;US 201662375050 P;;US 201762451566 P;;US 201762483932 P;;US 2017/0046918 W,2016-08-15,ANTI-BACKOUT LATCH FOR INTERCONNECT SYSTEM,"An interconnect system includes various anti-backout latches that are movable between an engaged position and a disengaged position. When in the engaged position, the anti-backout latches can be configured to prevent an interconnect module, such as an optical transceiver, from becoming unmated from a host module. When in the disengaged position, the anti-backout latches permit the interconnect module to become unmated from a host module. Securement members are also disclosed that secure a heat sink to a module housing of the interconnect module.",SAMTEC INC,PARKES LIAM;;ZBINDEN ERIC;;GUETIG KEITH;;SHAH JIGNESH H;;WILLIAMS BARNETT JEAN CARLO;;FAITH CHADRICK PAUL;;BETTMAN R BRAD,SAMTEC INC (2016-08-24),https://lens.org/190-214-339-285-88X,Patent Application,yes,0,4,14,23,0,H01R12/7005;;H01R13/629;;H01R13/639;;H01R24/20;;H01R13/639;;G02B6/428;;G02B6/4214;;G02B6/4284;;H01R12/774;;H01R12/83;;H01R12/7058;;H01R12/7029;;G02B6/4246;;G02B6/4269;;G02B6/4277;;H01R12/7029;;H01R12/7058;;H01R12/774;;H01R12/83;;H01R13/639;;H01R13/629,H01R12/70;;G02B6/42;;H01R12/77;;H01R12/83;;H01R13/639,,0,0,,,,ACTIVE
22,CN,A,CN 107768913 A,124-615-131-093-321,2018-03-06,2018,CN 201710696634 A,2017-08-15,US 201662375050 P;;US 201762451566 P;;US 201762483932 P,2016-08-15,Anti-backout latch for interconnect system,"An interconnect system includes various anti-backout latches that are movable between an engaged position and a disengaged position. When in the engaged position, the anti-backout latches can be configured to prevent an interconnect module, such as an optical transceiver, from becoming unmated from a host module. When in the disengaged position, the anti-backout latches permit the interconnect module to become unmated from a host module. Securement members are also disclosed that secure a heat sink to a module housing of the interconnect module.",SAMTEC INC,ERIC ZBINDEN;;R BRAD BETTMAN;;LIAM PARKES;;CHADRICK PAUL FAITH;;KEITH GUETIG;;JIGNESH H SHAH;;JEAN KARLO WILLIAMS BARNETT,,https://lens.org/124-615-131-093-321,Patent Application,no,13,1,14,23,0,H01R12/7005;;H01R13/629;;H01R13/639;;H01R24/20;;H01R13/639;;G02B6/428;;G02B6/4214;;G02B6/4284;;H01R12/774;;H01R12/83;;H01R12/7058;;H01R12/7029;;G02B6/4246;;G02B6/4269;;G02B6/4277;;H01R12/7029;;H01R12/7058;;H01R12/774;;H01R12/83;;H01R13/639;;H01R13/629,H01R13/639;;H01R12/70;;H01R13/629;;H01R24/20,,0,0,,,,ACTIVE
23,EP,A1,EP 3497755 A1,162-823-235-161-995,2019-06-19,2019,EP 17841983 A,2017-08-15,US 201662375050 P;;US 201762451566 P;;US 201762483932 P;;US 2017/0046918 W,2016-08-15,ANTI-BACKOUT LATCH FOR INTERCONNECT SYSTEM,,SAMTEC INC,PARKES LIAM;;ZBINDEN ERIC;;GUETIG KEITH;;SHAH JIGNESH H;;BARNETT JEAN KARLO WILIAMS;;FAITH CHADRICK PAUL;;BETTMAN R BRAD,,https://lens.org/162-823-235-161-995,Patent Application,yes,0,0,14,23,0,H01R12/7005;;H01R13/629;;H01R13/639;;H01R24/20;;H01R13/639;;G02B6/428;;G02B6/4214;;G02B6/4284;;H01R12/774;;H01R12/83;;H01R12/7058;;H01R12/7029;;G02B6/4246;;G02B6/4269;;G02B6/4277;;H01R12/7029;;H01R12/7058;;H01R12/774;;H01R12/83;;H01R13/639;;H01R13/629,H01R13/639;;G02B6/42;;H01R13/629,,0,0,,,,PENDING
24,US,B2,US 11196195 B2,171-899-144-628-008,2021-12-07,2021,US 201816604023 A,2018-04-10,US 201816604023 A;;US 201762483932 P;;US 201762595579 P;;US 201862639492 P;;US 2018/0026860 W,2017-04-10,Interconnect system having retention features,Interconnect systems having anti-backout latches and securement members are disclosed.,SAMTEC INC,BETTMAN R BRAD;;PARKES LIAM;;ZBINDEN ERIC;;GUETIG KEITH;;SHAH JIGNESH H;;WILLIAMS BARNETT JEAN KARLO;;FAITH CHADRICK PAUL;;LOY EDWIN,SAMTEC INC (2017-04-12),https://lens.org/171-899-144-628-008,Granted Patent,yes,90,1,9,23,0,G02B6/4284;;H01R12/7052;;H01R12/7058;;H01R12/721;;H01R12/73;;H01R13/502;;H01R13/639;;G02B6/4269;;G02B6/4284;;H01R12/7058;;H01R12/73,H01R12/70;;G02B6/42;;H01R12/73,,1,0,,,"Samtec, .8MM Q-Rate Terminal Assembly by Clay W, Dwg. No. QRM8-XXX-XX.X-X-D-XX-A-XX, Aug. 27, 2008, 4 sheets.",ACTIVE
25,US,A1,US 2020/0220286 A1,108-552-107-310-538,2020-07-09,2020,US 201816604023 A,2018-04-10,US 201816604023 A;;US 201762483932 P;;US 201762595579 P;;US 201862639492 P;;US 2018/0026860 W,2017-04-10,INTERCONNECT SYSTEM HAVING RETENTION FEATURES,Interconnect systems having anti-backout latches and securement members are disclosed.,SAMTEC INC,BETTMAN R BRAD;;PARKES LIAM;;ZBINDEN ERIC;;GUETIG KEITH;;SHAH JIGNESH H;;WILLIAMS BARNETT JEAN KARLO;;FAITH CHADRICK PAUL;;LOY EDWIN,SAMTEC INC (2017-04-12),https://lens.org/108-552-107-310-538,Patent Application,yes,0,8,9,23,0,G02B6/4284;;H01R12/7052;;H01R12/7058;;H01R12/721;;H01R12/73;;H01R13/502;;H01R13/639;;G02B6/4269;;G02B6/4284;;H01R12/7058;;H01R12/73,H01R12/70;;G02B6/42;;H01R12/73,,0,0,,,,ACTIVE
26,EP,A4,EP 3610311 A4,027-183-353-436-569,2020-12-09,2020,EP 18784893 A,2018-04-10,US 201762483932 P;;US 201762595579 P;;US 201862639492 P;;US 2018/0026860 W,2017-04-10,INTERCONNECT SYSTEM HAVING RETENTION FEATURES,,SAMTEC INC,BETTMAN BRAD R;;PARKES LIAM;;ZBINDEN ERIC;;GUETIG KEITH;;SHAH JIGNESH H;;WILLIAMS BARNETT JEAN KARLO;;FAITH CHADRICK PAUL;;LOY EDWIN,,https://lens.org/027-183-353-436-569,Search Report,no,2,0,9,23,0,G02B6/4284;;H01R12/7052;;H01R12/7058;;H01R12/721;;H01R12/73;;H01R13/502;;H01R13/639;;G02B6/4269;;G02B6/4284;;H01R12/7058;;H01R12/73,H01R13/639;;G02B6/42;;H01R12/70;;H01R12/72;;H01R12/73;;H01R12/77;;H01R12/83;;H01R13/502;;H01R13/629,,1,0,,,See also references of WO 2018191248A1,PENDING
27,EP,A1,EP 3610311 A1,047-610-479-926-52X,2020-02-19,2020,EP 18784893 A,2018-04-10,US 201762483932 P;;US 201762595579 P;;US 201862639492 P;;US 2018/0026860 W,2017-04-10,INTERCONNECT SYSTEM HAVING RETENTION FEATURES,,SAMTEC INC,BETTMAN BRAD R;;PARKES LIAM;;ZBINDEN ERIC;;GUETIG KEITH;;SHAH JIGNESH H;;WILLIAMS BARNETT JEAN KARLO;;FAITH CHADRICK PAUL;;LOY EDWIN,,https://lens.org/047-610-479-926-52X,Patent Application,yes,0,0,9,23,0,G02B6/4284;;H01R12/7052;;H01R12/7058;;H01R12/721;;H01R12/73;;H01R13/502;;H01R13/639;;G02B6/4269;;G02B6/4284;;H01R12/7058;;H01R12/73,G02B6/42;;G02B6/36,,0,0,,,,PENDING
28,CN,A,CN 110494784 A,038-103-116-086-979,2019-11-22,2019,CN 201880024043 A,2018-04-10,US 201762483932 P;;US 201762595579 P;;US 201862639492 P;;US 2018/0026860 W,2017-04-10,INTERCONNECT SYSTEM HAVING RETENTION FEATURES,Interconnect systems having anti-backout latches and securement members are disclosed.,SAMTEC INC,BETTMAN R BRAD;;PARKES LIAM;;ZBINDEN ERIC;;GUETIG KEITH;;SHAH JIGNESH H;;WILLIAMS BARNETT JEAN KARLO;;FAITH CHADRICK PAUL;;EDWIN ROY,,https://lens.org/038-103-116-086-979,Patent Application,no,9,0,9,23,0,G02B6/4284;;H01R12/7052;;H01R12/7058;;H01R12/721;;H01R12/73;;H01R13/502;;H01R13/639;;G02B6/4269;;G02B6/4284;;H01R12/7058;;H01R12/73,G02B6/42;;G02B6/36,,0,0,,,,ACTIVE
29,CN,A,CN 116014507 A,014-100-847-177-845,2023-04-25,2023,CN 202310101286 A,2019-07-11,US 201862697014 P;;US 201862728278 P;;US 201862704025 P;;US 201962704052 P;;US 201962813102 P;;US 201962840731 P;;CN 201980044835 A;;US 2019/0041356 W,2018-07-12,Cable connector system,"A cable connector system includes a cable including a center conductor and a housing supporting a portion of the center conductor. The imaginary line divides the cross section of the center conductor into two semicircles, and when the cable connector is docked with a docking connector, only one of the two semicircles is directly connected with a corresponding contact of the docking connector.",SAMTEC INC,JOHN A MONGOLD;;JONATHAN E BUCK;;JIGNESH H XIA;;FAITH CHADRICK P;;RANDLE E MATHER;;WILLIAMS BARNETT JEAN KARLO;;MCMORROW NORMAN S,,https://lens.org/014-100-847-177-845,Patent Application,no,0,0,11,56,0,H01R12/62;;H01R12/594;;H01R12/594;;H01R12/79;;H01R13/113;;H01R13/6587,H01R13/6461;;H01R12/70;;H01R13/648;;H01R24/00,,0,0,,,,PENDING
30,CN,A,CN 112753137 A,088-160-812-035-512,2021-05-04,2021,CN 201980062703 A,2019-10-08,US 201862704025 P;;US 201962704052 P;;US 201962813102 P;;US 201962840731 P;;US 2019/0041356 W;;US 2019/0055139 W,2018-10-09,CABLE CONNECTOR SYSTEMS,"A cable connector system can include a board connector that attaches to a die package, a cable connector that attaches to the board connector, and a 1RU panel I/O connector attached to the cable connector.",SAMTEC INC,MONGOLD JOHN A;;BUCK JONATHAN E;;SHAH JIGNESH H;;FAITH CHADRICK P;;MUSSER RANDALL E;;WILLIAMS BARNETT JEAN KARLO;;MCMORROW NORMAN S,,https://lens.org/088-160-812-035-512,Patent Application,no,16,0,12,56,0,H01R12/79;;H01R13/6587;;H01R12/79;;H01R13/518,H01R12/75;;H01R12/73;;H01R13/514;;H01R13/52,,0,0,,,,PENDING
